Table 1 Descriptive analysis for all cycles included.
Cycle characteristics | Total | Non-Consanguineous group | Consanguineous group | t-test | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
n | Mean ± SD | Min–Max | 95% CI | n | Mean ± SD | 95% CI | n | Mean ± SD | 95% CI | p (t-test) | |
Age (years) | 2564 | 34.7 ± 6.1 | 18–50 | 34.5–35.0 | 2024 | 35.1 ± 0.1 | 34.8–35.4 | 540 | 33.3 ± 0.3 | 32.8–33.8 |  < 0.001 |
Partner age (years) | 2564 | 39.4 ± 7.7 | 21–80 | 39.1–39.7 | 2024 | 39.8 ± 0.2 | 39.5–40.1 | 540 | 38.1 ± 0.3 | 37.5–38.6 |  < 0.001 |
Years of infertility | 2531 | 3.4 ± 3.4 | 0–25 | 3.3–3.6 | 1997 | 3.3 ± 0.1 | 3.1–3.4 | 534 | 4.0 ± 0.2 | 3.7–4.3 |  < 0.001 |
AMH (ng/mL) | 1749 | 2.5 ± 2.7 | 0.01–23 | 2.4–2.7 | 1303 | 2.5 ± 0.1 | 2.4–2.7 | 446 | 2.6 ± 0.1 | 2.3–2.8 | 0.3964 |
AFC | 2460 | 11.6 ± 7.9 | 0–61 | 11.3–11.9 | 1945 | 11.3 ± 0.2 | 11.0–11.7 | 515 | 12.5 ± 0.4 | 11.8–13.2 | 0.0015 |
BMI (kg/m2) | 1776 | 28.6 ± 4.8 | 14.3–45 | 28.4–28.8 | 1327 | 28.5 ± 0.1 | 28.3–28.8 | 449 | 28.7 ± 0.2 | 28.3–29.2 | 0.2193 |
MII inseminated oocytes | 2564 | 10.1 ± 6.5 | 50 | 9.9–10.4 | 2024 | 9.9 ± 0.1 | 9.7–10.2 | 540 | 10.8 ± 0.3 | 10.2–11.3 | 0.005 |
Fertilized (2PN) oocytes | 2564 | 7.3 ± 5.1 | 42.0 | 7.1–7.5 | 2024 | 7.2 ± 0.1 | 7.0–7.4 | 540 | 7.8 ± 0.2 | 7.3–8.2 | 0.0136 |
Fertilisation % | 2564 | 73.3 ± 19.3 | 5.3–100 | 72.6–74.1 | 2024 | 73.4 ± 0.4 | 72.6–74.2 | 540 | 73.0 ± 0.9 | 71.3–74.7 | 0.3421 |
Blastocyst biopsied % | 2564 | 61.1 ± 25.7 | 4.4–100 | 60.1–62.1 | 2024 | 61.2 ± 0.6 | 60.0–62.3 | 540 | 60.7 ± 1.1 | 58.6–62.8 | 0.3522 |
Euploid % | 2564 | 39.4 ± 35.2 | 0–100 | 38.1–40.8 | 2024 | 37.7 ± 0.8 | 36.2–39.3 | 540 | 45.8 ± 1.5 | 43.0–48.7 |  < 0.001 |
